SCHEMBL23722876

SCHEMBL23722876

CCN(CC)CCNC(=O)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.72
ALDH1A1 P00352 5/20 0.72
TP53 P04637 3/20 0.72
RAD52 P43351 2/20 0.72
GAA P10253 2/20 0.72
MAPT P10636 2/20 0.72
RXFP1 Q9HBX9 2/20 0.72
CACNA1B Q00975 2/20 0.72
APBA1 Q02410 2/20 0.72
NPC1 O15118 1/20 0.72
RAB9A P51151 1/20 0.72
UBE2I P63279 1/20 0.72
SAE1 Q9UBE0 1/20 0.72
UBA2 Q9UBT2 1/20 0.72
UBE2N P61088 1/20 0.71
HPGD P15428 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
ABCB11 O95342 1/20 0.66
LMNA P02545 1/20 0.66
CYP1A2 P05177 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23722863 0.98 KDM4E (0.70) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722843 0.93 RAD52 (0.81) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722895 0.93 TP53 (0.66) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722850 0.91 MAPT (0.66) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722919 0.89 TP53 (0.62) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722881 0.89 KDM4E (0.65) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722854 0.88 KDM4E (0.69) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL23722916 0.88 TP53 (0.67) KDM4EALDH1A1TP53RAD52GAA
SCHEMBL14970873 0.88 MOK (0.80) KDM4EALDH1A1TP53MAPTCACNA1B
SCHEMBL23722867 0.88 ALDH1A1 (0.58) KDM4EALDH1A1TP53RAD52GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210244721-A1 SMALL MOLECULE ENTEROVIRUS INHIBITORS AND USES THEREOF AR, KLK3, BRDT KDM4E 2146/4885ALDH1A1 3667/4885TP53 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.